Clinical value of geriatric nutritional risk index and pan-immune-inflammation value in locally advanced gastric cancer receiving neoadjuvant chemotherapy

Key Points

• The GNRI and PIV scores are predictive biomarkers that can determine outcomes in patients undergoing neoadjuvant chemotherapy for locally advanced gastric cancer.
• Patients receiving nutritional supplements show improved status, indicating a strong connection between nutrition and treatment effectiveness in this cancer population.
• Assessment of geriatric nutritional risk index and pan-immune-inflammation value can enhance personalized care for gastric cancer patients during treatment.
• Results suggest that integrating these scoring systems may lead to better patient management and outcomes in clinical settings.